Wolverine Trading, LLC Innoviva, Inc. Put Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 06, 2021	SELL	$11.45 - $13.96 $149,995 - $182,876	-13,100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $44,240 - $51,480	-4,000 Reduced 23.39%	13,100 $156,000
Q1 2020 May 11, 2020	SELL	$8.11 - $15.23 $1,622 - $3,046	-200 Reduced 1.16%	17,100 $199,000
Q4 2019 Feb 12, 2020	BUY	$10.28 - $14.38 $177,844 - $248,774	17,300 New	17,300 $245,000
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $256,275 - $371,025	-25,500 Closed	0 $0
Q2 2019 Aug 20, 2019	BUY	$13.1 - $14.95 $174,230 - $198,835	13,300 Added 109.02%	25,500 $371,000
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $35,594 - $52,156	-2,600 Reduced 17.57%	12,200 $171,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $89,700 - $110,434	-6,500 Reduced 30.52%	14,800 $247,000
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $249,849 - $314,175	21,300	21,300 $302,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.